Z

Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079

Watchlist Manager
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
Watchlist
Price: 17.72 CNY 5.98% Market Closed
Market Cap: 3.3B CNY

Intrinsic Value

The intrinsic value of one Zhejiang Shengda Bio-Pharm Co Ltd stock under the Base Case scenario is 6.83 CNY. Compared to the current market price of 17.72 CNY, Zhejiang Shengda Bio-Pharm Co Ltd is Overvalued by 61%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
6.83 CNY
Overvaluation 61%
Intrinsic Value
Price
Z
Worst Case
Base Case
Best Case

Valuation History
Zhejiang Shengda Bio-Pharm Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Zhejiang Shengda Bio-Pharm Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Zhejiang Shengda Bio-Pharm Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Zhejiang Shengda Bio-Pharm Co Ltd.

Explain Valuation
Compare Zhejiang Shengda Bio-Pharm Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Zhejiang Shengda Bio-Pharm Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zhejiang Shengda Bio-Pharm Co Ltd

Current Assets 961m
Receivables 156m
Other Current Assets 805m
Non-Current Assets 1.2B
Long-Term Investments 11m
PP&E 886m
Intangibles 236m
Other Non-Current Assets 52m
Current Liabilities 218m
Accounts Payable 172m
Accrued Liabilities 20m
Other Current Liabilities 26m
Non-Current Liabilities 353m
Long-Term Debt 306m
Other Non-Current Liabilities 47m
Efficiency

Free Cash Flow Analysis
Zhejiang Shengda Bio-Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Zhejiang Shengda Bio-Pharm Co Ltd

Revenue
839.8m CNY
Cost of Revenue
-636.8m CNY
Gross Profit
203m CNY
Operating Expenses
-121.5m CNY
Operating Income
81.5m CNY
Other Expenses
-20.4m CNY
Net Income
61.1m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Zhejiang Shengda Bio-Pharm Co Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Operating Margin is Increasing
Healthy Gross Margin
Gross Margin is Increasing
45/100
Profitability
Score

Zhejiang Shengda Bio-Pharm Co Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Zhejiang Shengda Bio-Pharm Co Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
77/100
Solvency
Score

Zhejiang Shengda Bio-Pharm Co Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Zhejiang Shengda Bio-Pharm Co Ltd

There are no price targets for Zhejiang Shengda Bio-Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Zhejiang Shengda Bio-Pharm Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Zhejiang Shengda Bio-Pharm Co Ltd stock?

The intrinsic value of one Zhejiang Shengda Bio-Pharm Co Ltd stock under the Base Case scenario is 6.83 CNY.

Is Zhejiang Shengda Bio-Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 17.72 CNY, Zhejiang Shengda Bio-Pharm Co Ltd is Overvalued by 61%.

Back to Top